Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

JUNE 7, 2021

Always consult a physician before attempting alternative therapies. However, Molly that has been seized by law enforcement has been found to contain other types of drugs too, some also contained no MDMA at all despite supposedly being the crystalline form of MDMA. . Conditions That Could Benefit from MDMA Therapy .

Therapy 85

Therapy Treatment Conditions Clinical Trials 85

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

Canna Care Docs

AUGUST 9, 2022

Thanks to a new Virginia law that went into effect on July 1, the registration process for medical cannabis patients is now quicker and less of a burden. This new change provides much needed relief for Virginia medical cannabis patients. How to become a medical cannabis patient in Virginia. Virginia is different, however.

Law 105

Law Patients Legislation Conditions 105

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

SEPTEMBER 30, 2022

Connecticut is slated to provide legal, state-supported MDMA and psilocybin therapy as early as next year. The northeast state seeks to provide qualified patients with funding to receive MDMA-assisted or psilocybin-assisted therapy as part of a Food and […].

Therapy 52

Therapy Legalization Food Treatment 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions.

Therapy 52

Therapy Access Clinical Trials Treatment 52

The Cannigma

JUNE 1, 2021

Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. The post Cannabis laws in France appeared first on The Cannigma.

Law 113

Law Epilepsy Programs Patients 113

The Cannigma

JUNE 2, 2023

The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. The law unequivocally prohibits the possession, consumption, importation, and trafficking of cannabis. Law enforcement agencies in Singapore actively combat drug offenses. Is weed legal in Singapore?

Law 52

Law Research and Development Consumption Therapy 52

Cannabis Law Report

OCTOBER 14, 2021

International Summit on Psychedelic Therapies for Mental Illness. Why do we need psychedelic-assisted therapies? Living until you die – the promise of psilocybin-assisted therapy with terminally ill patients. It’s got some big hitters. 19 and 20 November 2021. DAY 1: FRIDAY 19TH NOVEMBER. 8:45am – 9:15am (AEDT).

Therapy 105

Therapy Medicine Treatment Programs 105

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” Psychedelic therapy is not a fringe phenomenon. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

NORML

MAY 19, 2020

House lawmakers have overwhelmingly approved two bills to amend the state’s medical marijuana program in a manner that significantly expands patients’ access to cannabis products. The measure establishes regulations permitting the home delivery of medical cannabis products to registered patients.

Access 256

Access Therapy Patients Conditions 256

MMJ Recs

JANUARY 2, 2024

As scientific research delves deeper into medical cannabis for cancer patients, MMJ’s potential has come to the forefront, offering new hope for individuals grappling with the complexities of cancer. From their interactions with the endocannabinoid system to potential anti-cancer mechanisms, ongoing research is unraveling the complexities.

Treatment 98

Treatment Therapy Research and Development Patients 98

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! Verify your email address.

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

APRIL 17, 2023

KATU report SALEM, Ore. Oregon lawmakers are currently considering a bill that would require licensed psilocybin providers to submit data about their client’s demographics to state health officials.

Data 52

Data Collective Therapy Patients 52

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

MMJ Recs

OCTOBER 9, 2023

As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively. These centers differ in terms of services, expertise, and their approach to patient care. Top-Rated Medical Cannabis Clinics in Texas 1.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

NORML

MAY 27, 2020

Senators on Wednesday passed legislation to significantly expand the pool of patients eligible to qualify for medical cannabis access. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .”

Conditions 276

Conditions Legislation Therapy Patients 276

Canna Law Blog

NOVEMBER 1, 2021

The Physician Self-Referral Law, commonly referred to as the Stark law (42 U.S.C. 1395nn), is one of several federal fraud and abuse laws. While the two laws may seem similar at first, they have very different rules and penalties. The Stark law has civil penalties, while the AKS has civil and criminal penalties.

Law 87

Law Therapy Treatment Programs 87

Cannabis Law Report

SEPTEMBER 17, 2022

– September 15, 2022) – HealingMaps, an informative and trusted psychedelic therapy search site announced today the close of $1 Million USD in seed round funding from eight investors. Miami, Florida–(Newsfile Corp. The round was led by Phyto Partners along with Ambria Capital. ”

Therapy 52

Therapy Education Patients Treatment 52

United Patients Group

DECEMBER 9, 2023

Traditional treatments for chronic pain include over-the-counter medications, prescription painkillers, anti-inflammatory drugs, and physical therapy. Patients who have utilized medical marijuana for pain management have reported promising results, including reduced pain intensity, increased physical function, and improved sleep quality.

Chronic Pain 80

Chronic Pain Marijuana Patients Therapy 80

Cannabis Law Report

AUGUST 3, 2022

Eight Canadians have filed a Charter challenge against the Government of Canada and the Minister of Health regarding patient access to psilocybin and psilocybin therapy. It’s a similar argument to the landmark court case, R v Parker, which led to Canada’s first medical cannabis laws. The Patients / Plaintiffs.

Access 52

Access Patients Therapy Legalization 52

United Patients Group

NOVEMBER 21, 2023

Traditional treatments with prescription medications can sometimes be insufficient or accompanied by undesirable side effects, leaving patients in search of alternative methods for pain relief. Harlequin is ideal for patients seeking clear-headed pain relief during daytime hours.

Chronic Pain 80

Chronic Pain Strains Patients Marijuana 80

Veriheal

NOVEMBER 11, 2023

Simply put, in the eyes of federal law, cannabis is illegal. The Department of Veterans Affairs (VA) falls under federal government control which means it must obey all federal laws, including every cannabis law. According to Federal law, cannabis use is illegal. However, there can be penalties based on federal laws.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

DECEMBER 15, 2021

Another three patients who have petitioned the federal government to use psilocybin therapy as a treatment for their mental health conditions have received an exemption from the minister of health to legally undergo this therapy. . based non-profit TheraPsil, was one of the patients granted an exemption.

Patients 52

Patients Therapy Conditions Access 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. About RYAH Group, Inc.

Therapy 76

Therapy Data Research and Development Events 76

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Cannabis Law Report

APRIL 2, 2022

Five terminal cancer patients have been granted Canada’s first legal, domestic supply of magic mushrooms to treat their end-of-life anxiety. The Vancouver Sun writes. Having this approval, I feel like the luckiest person. I really didn’t think I was going to make it this long,” he said. Read the full atory at.

Patients 52

Patients Therapy Legalization 52